These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Hospital-based surveillance of invasive pneumococcal disease among young children in urban Nepal. Williams EJ; Thorson S; Maskey M; Mahat S; Hamaluba M; Dongol S; Werno AM; Yadav BK; Shah AS; Kelly DF; Adhikari N; Pollard AJ; Murdoch DR Clin Infect Dis; 2009 Mar; 48 Suppl 2():S114-22. PubMed ID: 19191606 [TBL] [Abstract][Full Text] [Related]
46. Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda. Kisakye A; Makumbi I; Nansera D; Lewis R; Braka F; Wobudeya E; Chaplain D; Nalumansi E; Mbabazi W; Gessner BD Clin Infect Dis; 2009 Mar; 48 Suppl 2():S153-61. PubMed ID: 19191611 [TBL] [Abstract][Full Text] [Related]
47. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. Muñoz-Almagro C; Esteva C; de Sevilla MF; Selva L; Gene A; Pallares R J Infect; 2009 Aug; 59(2):75-82. PubMed ID: 19576637 [TBL] [Abstract][Full Text] [Related]
48. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006. Tyrrell GJ; Lovgren M; Chui N; Minion J; Garg S; Kellner JD; Marrie TJ Vaccine; 2009 Jun; 27(27):3553-60. PubMed ID: 19464534 [TBL] [Abstract][Full Text] [Related]
49. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease. Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319 [TBL] [Abstract][Full Text] [Related]
50. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines. Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450 [TBL] [Abstract][Full Text] [Related]
51. Occurrence and clinical presentation of systemic pneumococcal infections in an unselected population in Oslo, Norway, between 1993 and 1997. Holm AM; Berild D; Ringertz SH; Håheim LL; Høiby EA Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):465-7. PubMed ID: 12111604 [TBL] [Abstract][Full Text] [Related]
52. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect? Moore MR; Whitney CG Clin Infect Dis; 2008 Jan; 46(2):183-5. PubMed ID: 18171248 [No Abstract] [Full Text] [Related]
53. Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Chiba N; Morozumi M; Sunaoshi K; Takahashi S; Takano M; Komori T; Sunakawa K; Ubukata K; Epidemiol Infect; 2010 Jan; 138(1):61-8. PubMed ID: 19538821 [TBL] [Abstract][Full Text] [Related]
54. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449 [TBL] [Abstract][Full Text] [Related]
55. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605 [TBL] [Abstract][Full Text] [Related]
56. Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults. Benin AL; O'Brien KL; Watt JP; Reid R; Zell ER; Katz S; Donaldson C; Parkinson A; Schuchat A; Santosham M; Whitney CG J Infect Dis; 2003 Jul; 188(1):81-9. PubMed ID: 12825175 [TBL] [Abstract][Full Text] [Related]
57. Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population. Temime L; Boelle PY; Opatowski L; Guillemot D PLoS One; 2008 Sep; 3(9):e3244. PubMed ID: 18802466 [TBL] [Abstract][Full Text] [Related]
58. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004). Shibl AM Clin Microbiol Infect; 2008 Sep; 14(9):876-9. PubMed ID: 18844690 [TBL] [Abstract][Full Text] [Related]
59. The transforming Streptococcus pneumoniae in the 21st century. Hsieh YC; Lee WS; Shao PL; Chang LY; Huang LM Chang Gung Med J; 2008; 31(2):117-24. PubMed ID: 18567411 [TBL] [Abstract][Full Text] [Related]
60. From global to regional: the importance of pneumococcal disease in Latin America. de Quadros CA Vaccine; 2009 Aug; 27 Suppl 3():C29-32. PubMed ID: 19540025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]